OptimizeRx CorporationOPRXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +13.91% | +11.37% | +55.19% | +22.33% | -0.24% |
| Gross Profit Growth | +23.44% | +9.34% | +59.22% | +30.26% | -10.22% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +100.35% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +145.90% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +4.37% | +1.65% | +1.39% | +1.07% | +1.32% |
| Weighted Average Shares Diluted Growth | +4.37% | +1.65% | +4.15% | +3.81% | +5.23% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +82.44% | +483.25% | +78.78% | +3479.80% |
| Free Cash Flow Growth | +0.00% | +95.27% | +552.94% | +87.88% | +8973.08% |
| Receivables Growth | +2.48% | +6.66% | +29.57% | +22.11% | -1.20% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -6.66% | -4.88% | -2.09% | +3.10% | +3.36% |
| Book Value per Share Growth | -11.42% | -6.66% | -2.78% | +5.68% | +8.23% |
| Debt Growth | -9.86% | -10.04% | -19.71% | -19.90% | -21.36% |
| R&D Expense Growth | +0.00% | +28.17% | -100.00% | -12.09% | +0.00% |
| SG&A Expenses Growth | -8.29% | -11.15% | -0.06% | +7.16% | -29.89% |